{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:21:01Z","timestamp":1792682461664,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jgar.2020.08.021","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:48:15Z","timestamp":1599004095000},"page":"136-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Jiating","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.08.021_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkx368","article-title":"Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"73","author":"Kengkla","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2334-14-102","article-title":"Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis","volume":"14","author":"Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.021_bib0015","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/AAC.01520-13","article-title":"Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes","volume":"57","author":"Chopra","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2147\/IDR.S239514","article-title":"Burden of multidrug-resistant acinetobacter baumannii infection in hospitalized patients in a tertiary care hospital of Nepal","volume":"13","author":"Yadav","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2020.08.021_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bjid.2012.10.029","article-title":"Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis","volume":"17","author":"Chu","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.021_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/00365548.2014.995129","article-title":"Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex","volume":"47","author":"Lin","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jgar.2020.08.021_bib0035","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/MJT.0b013e3182a32df3","article-title":"Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam","volume":"23","author":"Zalts","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.jgar.2020.08.021_bib0040","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0885066617725694","article-title":"Efficacy and safety of high loading dose of colistin in multidrug-resistant Acinetobacter baumannii: a prospective cohort study","volume":"34","author":"Katip","year":"2019","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jgar.2020.08.021_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/IDR.S144314","article-title":"Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients","volume":"10","author":"Katip","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2020.08.021_bib0050","first-page":"311","article-title":"Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia","volume":"25","author":"Alp","year":"2017","journal-title":"Infez Med"},{"key":"10.1016\/j.jgar.2020.08.021_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jiac.2019.03.017","article-title":"Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii","volume":"25","author":"Chusri","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0060","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/IDR.S234211","article-title":"Colistin plus carbapenem versus colistin monotherapy in the treatment of carbapenem-resistant acinetobacter baumannii pneumonia","volume":"12","author":"Shi","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2020.08.021_bib0065","first-page":"2847","article-title":"[Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections]","volume":"92","author":"Shi","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jgar.2020.08.021_bib0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0255-0857.103767","article-title":"Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: monotherapy or combination therapy?","volume":"30","author":"Simsek","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jgar.2020.08.021_bib0075","first-page":"778","article-title":"Nephrotoxicity of high and conventional dosing regimens of colistin: a randomized clinical trial","volume":"16","author":"Javan","year":"2017","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.jgar.2020.08.021_bib0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcrc.2017.04.004","article-title":"Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii","volume":"40","author":"Jang","year":"2017","journal-title":"J Crit Care"},{"key":"10.1016\/j.jgar.2020.08.021_bib0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-017-1916-6","article-title":"Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis","volume":"21","author":"Jung","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.jgar.2020.08.021_bib0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jiac.2017.01.005","article-title":"Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: a systematic review and meta-analysis","volume":"23","author":"Chen","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/1120009X.2020.1716478","article-title":"Extensively-drug resistant Acinetobacter baumannii bacteremia in neonates: effective treatment with the combination of colistin and ampicillin\/sulbactam","volume":"32","author":"Gkentzi","year":"2020","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","article-title":"Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction","volume":"18","author":"Coates","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2020.08.021_bib0105","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/mdr.2018.0283","article-title":"Pharmacodynamic effects of Sulbactam\/Meropenem\/Polymyxin-B combination against extremely drug resistant Acinetobacter baumannii using checkerboard information","volume":"25","author":"Menegucci","year":"2019","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2020.08.021_bib0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.21037\/apm.2019.11.06","article-title":"Efficacy of tigecycline monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii sequence type 2 in Heilongjiang Province","volume":"8","author":"Li","year":"2019","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jgar.2020.08.021_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IDR.S182585","article-title":"In vitro activity of colistin in combination with various antimicrobials against acinetobacter baumannii species, a report from South Iran","volume":"12","author":"Kheshti","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2020.08.021_bib0120","article-title":"Acinetobacter baumannii ventilator-associated pneumonia: clinical efficacy of combined antimicrobial therapy and in vitro drug sensitivity test results","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgar.2020.08.021_bib0125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01268-16","article-title":"High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model","volume":"61","author":"Lenhard","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0130","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1093\/jac\/dkz337","article-title":"Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis","volume":"74","author":"Mei","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciy988","article-title":"Treatment outcomes of colistin- and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial","volume":"69","author":"Dickstein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.021_bib0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijantimicag.2017.12.020","article-title":"Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis","volume":"51","author":"Vardakas","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.08.021_bib0145","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7080208","article-title":"Intravenous colistin monotherapy versus combination therapy against carbapenem-resistant gram-negative bacteria infections: meta-analysis of randomized controlled trials","volume":"7","author":"Cheng","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.jgar.2020.08.021_bib0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgar.2020.08.021_bib0155","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jgar.2020.08.021_bib0160","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jgar.2020.08.021_bib0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jgar.2020.08.021_bib0170","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jgar.2020.08.021_bib0175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmi.2017.09.016","article-title":"The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii","volume":"24","author":"Amat","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.08.021_bib0180","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1017\/S095026881200194X","article-title":"Colistin vs. The combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"141","author":"Aydemir","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jgar.2020.08.021_bib0185","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10096-014-2070-6","article-title":"Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections","volume":"33","author":"Batirel","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.021_bib0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.021_bib0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000356004","article-title":"Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"59","author":"Garnacho-Montero","year":"2013","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jgar.2020.08.021_bib0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s15010-013-0495-y","article-title":"Comparison of colistin and colistin\/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"42","author":"Kalin","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2020.08.021_bib0205","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2217\/cer-2018-0037","article-title":"Meropenem\/colistin versus meropenem\/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia","volume":"7","author":"Khalili","year":"2018","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.jgar.2020.08.021_bib0210","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2014.01.016","article-title":"Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia","volume":"43","author":"Khawcharoenporn","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.08.021_bib0215","first-page":"206","article-title":"Interim study: comparison of safety and efficacy of levofloxacin plus colistin regimen with levofloxacin plus high dose ampicillin\/ sulbactam infusion in treatment of ventilator-associated pneumonia due to multi drug resistant acinetobacter","volume":"17","author":"Mosaed","year":"2018","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.jgar.2020.08.021_bib0220","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1177\/0300060519879336","article-title":"Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem","volume":"47","author":"Park","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jgar.2020.08.021_bib0225","first-page":"269","article-title":"Comparison of intravenous ampicillin\u2013sulbactam plus nebulized colistin with intravenous colistin plus nebulized colistin in treatment of ventilator associated pneumonia caused by multi drug resistant acinetobacter baumannii: Randomized open label trial","volume":"18","author":"Pourheidar","year":"2019","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.jgar.2020.08.021_bib0230","first-page":"430","article-title":"Tigecycline combined with cefoperazone-sulbactam in treatment of hospital-acquired pneumonia caused by extensively drug resistant Acinetobacter baumannii","volume":"15","author":"Qin","year":"2015","journal-title":"Chinese J Infect Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0235","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/AAC.02435-13","article-title":"Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections","volume":"58","author":"Sirijatuphat","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.021_bib0240","first-page":"2996","article-title":"[Efficacy of extended-infusion of carbapenem plus sulbactam for ventilator-associated pneumonia caused by extensive drug-resistant Acinetobacter baumannii]","volume":"97","author":"Wang","year":"2017","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jgar.2020.08.021_bib0245","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3855\/jidc.6195","article-title":"Colistin alone or combined with sulbactam or carbapenem against A. Baumannii in ventilator-associated pneumonia","volume":"9","author":"Yilmaz","year":"2015","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2020.08.021_bib0250","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2147\/IDR.S225518","article-title":"Clinical outcomes of colistin in combination with either 6-G sulbactam or carbapenems for the treatment of extensively drug-resistant Acinetobacter baumannii pneumonia with high MIC to sulbactam, a prospective cohort study","volume":"12","author":"Ungthammakhun","year":"2019","journal-title":"Infect Drug Resist"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:58:32Z","timestamp":1761991112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520302277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":50,"alternative-id":["S2213716520302277"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.08.021","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}